Betterlife Pharma Stock Market Capitalization
| BETRF Stock | USD 0.08 0.01 9.59% |
BetterLife Pharma fundamentals help investors to digest information that contributes to BetterLife Pharma's financial success or failures. It also enables traders to predict the movement of BetterLife OTC Stock. The fundamental analysis module provides a way to measure BetterLife Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BetterLife Pharma otc stock.
BetterLife |
BetterLife Pharma OTC Stock Market Capitalization Analysis
BetterLife Pharma's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current BetterLife Pharma Market Capitalization | 9.49 M |
Most of BetterLife Pharma's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BetterLife Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of BetterLife Pharma is about 9.49 M. This is 99.93% lower than that of the Healthcare sector and 99.8% lower than that of the Biotechnology industry. The market capitalization for all United States stocks is 99.95% higher than that of the company.
BetterLife Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BetterLife Pharma's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of BetterLife Pharma could also be used in its relative valuation, which is a method of valuing BetterLife Pharma by comparing valuation metrics of similar companies.BetterLife Pharma is currently under evaluation in market capitalization category among its peers.
BetterLife Fundamentals
| Return On Equity | -44.17 | |||
| Return On Asset | -4.05 | |||
| Current Valuation | 12.42 M | |||
| Shares Outstanding | 90.1 M | |||
| Shares Owned By Insiders | 8.41 % | |||
| Price To Book | 13.65 X | |||
| Gross Profit | (22.81 K) | |||
| EBITDA | (11.92 M) | |||
| Net Income | (12.16 M) | |||
| Cash And Equivalents | 14.41 K | |||
| Total Debt | 34.56 K | |||
| Debt To Equity | 0.25 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | (11.2 M) | |||
| Earnings Per Share | (0.12) X | |||
| Beta | 1.62 | |||
| Market Capitalization | 9.49 M | |||
| Total Asset | 1.16 M | |||
| Net Asset | 1.16 M |
About BetterLife Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BetterLife Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BetterLife Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BetterLife Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in BetterLife OTC Stock
BetterLife Pharma financial ratios help investors to determine whether BetterLife OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BetterLife with respect to the benefits of owning BetterLife Pharma security.